Our second event of the year was held in mid-September 2015, on the separate topics of Simulation and Hypothesis Testing. We were pleased to have speakers Andrew Grieve and Anne Benoit join us to present their work published in Pharmaceutical Statistics. The event was scheduled for 2 pm (UK time, BST) on the 16th September 2015.
Chair: Ray Harris (Eisai)
Speaker: Andrew P. Grieve (ICON Adaptive Trials Innovation Centre)
How to test hypotheses if you must
Author: Andrew P. Grieve
Pharmaceutical Statistics, Volume 14, Issue 2, Pages 139-150, March/April 2015
Links: Abstract | Paper+ | Slides
Speaker: Anne Benoit (Université catholique de Louvain and GSK Biologicals)
Influenza vaccine efficacy trials: a simulation approach to understand failures from the past
Authors: Anne Benoit, Catherine Legrand and Walthère Dewé
Pharmaceutical Statistics, Volume 14, Issue 4, Pages 294-301, July/August 2015
Links: Abstract | Paper+ | Slides
+ Papers freely available for all to view from 9th September 2015 to 7th October 2015. Available to journal subscribers at any time.
For a flier advertising the event, please click here.
For further information on future events, please visit the Journal Club homepage.
To access the recording, please visit the Video-on-Demand Library.
This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.
This webinar will explore two different approaches to Correlates of Protection in vaccine development.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.
